Michael Weiss
Gastroenterology · Ft Myers, FLNPI 1568445955
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 316 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 50.3% of the total. Reporting peaked in 2021 at $1,900 and has fallen 94.3% since, to $108 in 2025.
Across 316 payments — averaging $20.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$653
- Pfizer$607
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$541
- Janssen Scientific Affairs, LLC$239
- Takeda Pharmaceuticals U.S.A., Inc.$182
- plus $1K from 17 others
Across 18 payments — averaging $6773.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$122K
- Bristol Myers Squibb$4
What the payments were for
- Food & beverage$6,41197%
- Education$1753%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 134 | $3,310 |
| Johnson & Johnson | 44 | $653 |
| Pfizer | 31 | $607 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 29 | $541 |
| Janssen Scientific Affairs, LLC | 3 | $239 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $182 |
| Bristol Myers Squibb | 10 | $181 |
| Gilead | 18 | $151 |
| Daiichi Sankyo Inc. | 6 | $132 |
| Merck | 3 | $77 |
| QOL Medical, LLC | 3 | $68 |
| Ironwood Pharmaceuticals, Inc | 3 | $62 |
| Redhill Biopharma Inc. | 4 | $52 |
| Ardelyx, Inc. | 2 | $51 |
| Sanofi | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| Nestle Healthcare Nutrition Inc. | 2 | $39 |
| Intuitive Surgical | 1 | $36 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Fresenius Kabi USA, LLC | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Inari Medical, Inc. | 1 | $20 |
| Shire North American Group Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,586 in reported general payments places this provider in the 70th percentile of 1,388 gastroenterology providers in Florida.
Other gastroenterology in Ft Myers
- Samuel GidayOrlando$2M
- Lukasz KwapiszMiami$1.2M
- Jennifer Seminerio-DiehlOrlando$1.1M
- Udayakumar NavaneethanSaint Petersburg$1.1M
- Ronen AraiCoral Springs$1.1M
- Charles SninskyGainesville$983K
- Peter DraganovGainesville$832K
- Arin NewmanMiami Beach$716K
- Joanna LopezMiami$670K
- Jose NietoSebring$573K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.